FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128275005> ?p ?o ?g. }

• W3128275005 endingPage "e43" @default.
• W3128275005 startingPage "e40" @default.
• W3128275005 abstract "Objectives: The purpose of this study was to assess the feasibility and clinical impact of telemedicine-based opioid treatment with buprenorphine-naloxone following the Coronavirus disease 2019 pandemic. Methods: Participants included in this retrospective analysis consisted of adult New York City residents with opioid use disorder eligible for enrollment in the NYC Health+Hospitals Virtual Buprenorphine Clinic between March and May 2020 (n = 78). Follow-up data were comprised of rates of retention in treatment at 2 months, referrals to community treatment, and induction-related events. Results: During the initial 9 weeks of clinic operations, the clinic inducted 78 patients on to buprenorphine-naloxone and completed 252 visits. Patient referrals included non-NYC Health + Hospitals (n = 22, 28.2%) and NYC Health + Hospitals healthcare providers (n = 17, 21.8%), homeless shelter staff (n = 13, 16.7%), and the NYC Health + Hospitals jail reentry program in Rikers Island (n = 11, 14.1%). At 8 weeks, 42 patients remained in care (53.8%), 21 were referred to a community treatment program (26.9%), and 15 were lost to follow-up (19.2%). No patients were terminated from care due to disruptive behavior or suspicions of diversion or misuse of Buprenorphine. Adverse clinical outcomes were uncommon and included persistent withdrawal symptoms (n = 8, 4.3%) and one nonfatal opioid overdose (0.5%). Conclusions: Telemedicine-based opioid treatment and unobserved home induction on buprenorphine-naloxone offers a safe and feasible approach to expand the reach of opioid use disorder treatment, primary care, and behavioral health for a highly vulnerable urban population during an unprecedented natural disaster." @default.
• W3128275005 created "2021-02-15" @default.
• W3128275005 creator A5002428532 @default.
• W3128275005 creator A5009698132 @default.
• W3128275005 creator A5012561689 @default.
• W3128275005 creator A5023380781 @default.
• W3128275005 creator A5024703190 @default.
• W3128275005 creator A5033433488 @default.
• W3128275005 creator A5050087680 @default.
• W3128275005 creator A5069352572 @default.
• W3128275005 creator A5071630432 @default.
• W3128275005 creator A5077801791 @default.
• W3128275005 date "2021-02-05" @default.
• W3128275005 modified "2023-10-10" @default.
• W3128275005 title "A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic" @default.
• W3128275005 cites W2078154157 @default.
• W3128275005 cites W2509522044 @default.
• W3128275005 cites W2575251737 @default.
• W3128275005 cites W2594272477 @default.
• W3128275005 cites W2616473434 @default.
• W3128275005 cites W2894369234 @default.
• W3128275005 cites W2969791529 @default.
• W3128275005 cites W3014703200 @default.
• W3128275005 cites W3014861007 @default.
• W3128275005 doi "https://doi.org/10.1097/adm.0000000000000809" @default.
• W3128275005 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8339146" @default.
• W3128275005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33560696" @default.
• W3128275005 hasPublicationYear "2021" @default.
• W3128275005 type Work @default.
• W3128275005 sameAs 3128275005 @default.
• W3128275005 citedByCount "40" @default.
• W3128275005 countsByYear W31282750052021 @default.
• W3128275005 countsByYear W31282750052022 @default.
• W3128275005 countsByYear W31282750052023 @default.
• W3128275005 crossrefType "journal-article" @default.
• W3128275005 hasAuthorship W3128275005A5002428532 @default.
• W3128275005 hasAuthorship W3128275005A5009698132 @default.
• W3128275005 hasAuthorship W3128275005A5012561689 @default.
• W3128275005 hasAuthorship W3128275005A5023380781 @default.
• W3128275005 hasAuthorship W3128275005A5024703190 @default.
• W3128275005 hasAuthorship W3128275005A5033433488 @default.
• W3128275005 hasAuthorship W3128275005A5050087680 @default.
• W3128275005 hasAuthorship W3128275005A5069352572 @default.
• W3128275005 hasAuthorship W3128275005A5071630432 @default.
• W3128275005 hasAuthorship W3128275005A5077801791 @default.
• W3128275005 hasBestOaLocation W31282750052 @default.
• W3128275005 hasConcept C118552586 @default.
• W3128275005 hasConcept C126322002 @default.
• W3128275005 hasConcept C138816342 @default.
• W3128275005 hasConcept C159110408 @default.
• W3128275005 hasConcept C160735492 @default.
• W3128275005 hasConcept C162324750 @default.
• W3128275005 hasConcept C170493617 @default.
• W3128275005 hasConcept C194828623 @default.
• W3128275005 hasConcept C2778750930 @default.
• W3128275005 hasConcept C2778949969 @default.
• W3128275005 hasConcept C2779134260 @default.
• W3128275005 hasConcept C2779418921 @default.
• W3128275005 hasConcept C2779891985 @default.
• W3128275005 hasConcept C2780724011 @default.
• W3128275005 hasConcept C2781063702 @default.
• W3128275005 hasConcept C3008058167 @default.
• W3128275005 hasConcept C50522688 @default.
• W3128275005 hasConcept C512399662 @default.
• W3128275005 hasConcept C524204448 @default.
• W3128275005 hasConcept C545542383 @default.
• W3128275005 hasConcept C71924100 @default.
• W3128275005 hasConcept C89623803 @default.
• W3128275005 hasConceptScore W3128275005C118552586 @default.
• W3128275005 hasConceptScore W3128275005C126322002 @default.
• W3128275005 hasConceptScore W3128275005C138816342 @default.
• W3128275005 hasConceptScore W3128275005C159110408 @default.
• W3128275005 hasConceptScore W3128275005C160735492 @default.
• W3128275005 hasConceptScore W3128275005C162324750 @default.
• W3128275005 hasConceptScore W3128275005C170493617 @default.
• W3128275005 hasConceptScore W3128275005C194828623 @default.
• W3128275005 hasConceptScore W3128275005C2778750930 @default.
• W3128275005 hasConceptScore W3128275005C2778949969 @default.
• W3128275005 hasConceptScore W3128275005C2779134260 @default.
• W3128275005 hasConceptScore W3128275005C2779418921 @default.
• W3128275005 hasConceptScore W3128275005C2779891985 @default.
• W3128275005 hasConceptScore W3128275005C2780724011 @default.
• W3128275005 hasConceptScore W3128275005C2781063702 @default.
• W3128275005 hasConceptScore W3128275005C3008058167 @default.
• W3128275005 hasConceptScore W3128275005C50522688 @default.
• W3128275005 hasConceptScore W3128275005C512399662 @default.
• W3128275005 hasConceptScore W3128275005C524204448 @default.
• W3128275005 hasConceptScore W3128275005C545542383 @default.
• W3128275005 hasConceptScore W3128275005C71924100 @default.
• W3128275005 hasConceptScore W3128275005C89623803 @default.
• W3128275005 hasIssue "1" @default.
• W3128275005 hasLocation W31282750051 @default.
• W3128275005 hasLocation W31282750052 @default.
• W3128275005 hasLocation W31282750053 @default.
• W3128275005 hasOpenAccess W3128275005 @default.
• W3128275005 hasPrimaryLocation W31282750051 @default.
• W3128275005 hasRelatedWork W2898142040 @default.
• W3128275005 hasRelatedWork W2899266174 @default.

• next